logo-loader

XPhyto to take big steps forward in 2021 in diagnostics, drug formulations, and psychedelics

Published: 16:41 19 Jan 2021 GMT

XPhyto Therapeutics (CSE: XPHY- OTCQB: XPHYF) CEO Hugh Rogers joined Steve Darling from Proactive to provide an update on what the company is planning for a very busy 2021. Rogers laying out the plan for three areas of their business.

Rogers telling Proactive they expect major steps forward in their Diagnostic, Drug Formulation, and Psychedelics divisions.

Oriole Resources outlines 2023 achievements and future exploration plans

Oriole Resources PLC (AIM:ORR) CEO Tim Livesey and chief financial officer Bob Smeeton join Proactive's Stephen Gunnion with details of the company's 2023 financial and operational performance. Livesey highlighted successful exploration programs in Cameroon, at the Bibemi and Mbe projects,...

2 hours, 59 minutes ago